Dr Osaid H. Alser
Postdoctoral research fellow, Trauma, Emergency Surgery and Surgical Care, Massachusetts General Hospital, Harvard Medical School
I have been involved in COVID-19 research with two research groups in Oxford ((OHDSI/NDORMS) and (Oxford University Global Surgery Group (OUGSG)/GTC/NDORMS) with whom I have an honorary academic fellow contract, and with other research groups in Palestine (OxPal Medlink) and at Harvard.
Some examples of my work:
With the OHDSI:
-Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study.
–An international characterisation of patients hospitalised with COVID-19 and a comparison with those previously hospitalised with influenza
With the OUGSG:
-Infection and mortality of healthcare workers worldwide from COVID-19: a scoping review
-Healthcare workers preparedness for COVID-19 pandemic in the occupied Palestinian territory: a cross-sectional survey
In a study recently published in the Lancet we have looked at the complications following surgery for patients with a peri-operative COVID-19 diagnosis. We have found that the mortality rate was 24% and the risk of pulmonary complication was 51%. This is the largest multi-centre study to-date to evaluate these complications in COVID-19 patients undergoing surgery. My involvement was in the writing and in the dissemination committees of COVIDSurg Collaborative which is leading the project.
For more details please visit the COVIDSurg Twitter page.